Status:
COMPLETED
Shared Decision-Making: AFib 2gether Mobile App
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
Pfizer
Conditions:
Atrial Fibrillation New Onset
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patie...
Eligibility Criteria
Inclusion
- Providers:
- Caring for at least 3 patients aged 18 years and older
- Have at least 3 patients with International Classification of Diseases tenth revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter
- Have at least 3 patients with a CHA2DS2-VASc stroke risk score of 2 or more
- Have at least 3 patients who are not on anticoagulation
- Have at least 3 patients with upcoming appointments within the next 4 months
- Patients:
- Age 18+
- Preferred language is English
- Atrial fibrillation diagnosis
- Chads vasc score 2 or higher
- Not on anticoagulants
- No watchman or atrial appendage closure
- Had an ambulatory care center (ACC) cardiology appointment in the past 12 months
- Future appointment in the next 4 months with the same provider
Exclusion
- Providers:
- Providers who do not care for at least 3 patients aged 18 years and older
- Have patients that do not have an ICD-10 diagnostic code consistent with AF or atrial flutter
- Does not have patients with a CHA2DS2-VASc stroke risk score of 2 or more
- Their patients are on anticoagulation
- Their 3 patients do not have an upcoming visit within the next 4 months
- Patients:
- Under the age of 18; patients
- No ICD-10 diagnostic code consistent with AF or atrial flutter
- Did not have a visit with a cardiovascular medicine specialist in the previous one year
- Patients with a CHA2DS2-VASc score less than 2
- Currently prescribed an anticoagulant
- No upcoming cardiology visit in the next 3 months
- Has a WATCHMAN device or left atrial appendage closure surgery
- On hospice or for whom life expectancy is less than six months and patients
- Bleeding episode or fall with injury in the last four weeks
- Does not speak English
- Prisoner
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 26 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04118270
Start Date
November 1 2019
End Date
June 26 2020
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMass Medical School
Worcester, Massachusetts, United States, 01655